Take Control

Whether

you prefer to give yourself WAINUA with the WAINUA autoinjector or have your healthcare provider give you the injection, the choice is yours.

WAINUA® (eplontersen) Autoinjector

WAINUA
Autoinjector

Administered at home (or on the go) by you or a caregiver*

*Proper storage required.

Who is it for?

Adults who prefer to self-administer WAINUA on their own or with support from a caregiver

How will I receive it?

Delivered to your home by a specialty pharmacy

Frequency of WAINUA® (eplontersen) Dosing

It’s taken
once monthly

WAINUA won’t wear off between doses.

WAINUA Educational Resources

The actual injection
takes just 10 seconds†

You can take WAINUA by yourself, or someone can help you. Preparation is required.† Be sure to read the complete Instructions for Use.

†Preparation: bring device to room temperature (30 minutes), check device, and prepare injection site. Read Instructions for Use for full directions. Your healthcare provider should show you how to prepare and inject WAINUA the first time.

WAINUA® (eplontersen) Storage

Easy
storage

WAINUA can be stored at room temperature for up to 6 weeks.‡

‡Store WAINUA in its carton in the refrigerator between 36 °F to 46 °F (2 °C to 8 °C). Do not freeze. WAINUA can be stored at room temperature up to 86 °F (30 °C) for up to 6 weeks. Do not let WAINUA reach temperatures above 86 °F (30 °C) or expose to heat. Throw away WAINUA if kept at room temperature longer than 6 weeks.

Watch the autoinjector instructional video

The instructional video shows you how to take WAINUA using the autoinjector, step by step. Be sure to ask your healthcare provider to show you how to take WAINUA before your first dose.

No matter which administration option you choose:

WAINUA was proven to significantly reduce disease severity across a range of neuropathy symptoms and their impact on daily life§

Individual results may vary.
WAINUA may cause side effects, including low vitamin A level, a serious, but common side effect. See additional Important Safety Information below.

§As measured by mNIS+7 score and Norfolk QoL-DN score. The WAINUA-treated group had a significant improvement in neuropathy impairment (mNIS+7 score) and quality of life (Norfolk QoL-DN score) after 35 weeks in a clinical trial of adults with hATTR-PN. Improvement was defined as the difference between the change from baseline in the WAINUA group and a placebo group from a similar study.

Want a demonstration autoinjector?

If you've been prescribed WAINUA, you can receive a demonstration autoinjector, without a needle or medication, to practice injecting. Enrollment in WAINUA WAY is required.

Enroll now
WAINUA Autoinjector Demonstration

One-on-one injection support

Your Patient Education Manager can meet with you at home or virtually to share resources on how to take WAINUA.

Get connected with a Patient Education Manager
WAINUA Way Logo

Is committed to supporting you throughout your treatment

Learn about WAINUA WAY
WAINUA Sign Up Banner WAINUA Sign Up Banner
WAINUA WAY White Logo

Sign up today

Everyone’s invited to sign up for hATTR-PN information and WAINUA updates. If you’ve been prescribed WAINUA, you can also enroll in WAINUA WAY and receive:

  • Answers about your savings options
  • A dedicated point of contact for one-on-one support
  • A welcome kit and ongoing email updates

Whether you’ve been prescribed WAINUA or not, sign up today.

Let’s get started

Important Safety Information

WAINUA may cause side effects, including:

Low vitamin A level, which is a serious, but common side effect of treatment with WAINUA. Your doctor should tell you to take vitamin A supplements. Do not take more than the amount of vitamin A your doctor has recommended. Call your doctor if you develop eye problems such as difficulty seeing at night or in low-lit areas (night blindness), or dry eyes. If you develop eye problems, your doctor should refer you to an eye doctor

APPROVED USES

WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

The most common side effects include decreased vitamin A and vomiting.

Before you take WAINUA, tell your healthcare provider:

  • if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if WAINUA can harm your baby. Changes in vitamin A levels and vitamin A supplementation related to use of WAINUA may harm your unborn baby. It is not known if WAINUA passes into breast milk
  • about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take vitamin A or beta-carotene supplements

APPROVED USES

WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

Please see full Prescribing Information, including Patient Information.

You may report side effects related to AstraZeneca products .

Important Safety Information

 +